Overview
- Product nameAnti-Soluble TNF Receptor II antibodySee all Soluble TNF Receptor II primary antibodies ...
- DescriptionRabbit polyclonal to Soluble TNF Receptor II
- Tested applicationsWB, Indirect ELISA, Sandwich ELISA, Neutralising more details
- Species reactivityReacts with: Human
- Immunogen
Highly pure (>98%) recombinant Human Soluble TNF Receptor II.
Properties
- FormLyophilised:Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1 - 1.0 mg/ml.
- Storage instructionsStore at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.
- Storage bufferPreservative: None
Constituents: PBS, pH 7.2 -
Concentration information loading... - PurityImmunogen affinity purified
- Purification notesab109853 was purified by affinity chromatography employing immobilized Soluble TNF Receptor II matrix.
- Clonality Polyclonal
- IsotypeIgG
- Research Areas
Applications
Our Abpromise guarantee covers the use of ab109853 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| WB | WB: Use a concentration of 0.1 - 0.2 µg/ml. Predicted molecular weight: 48 kDa. |
| Indirect ELISA | I-ELISA: Use a concentration of 0.5 - 2 µg/ml. (using 100 µl/well antibody solution). This antigen affinity purified antibody, in conjunction with compatible secondary reagents, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human soluble TNF Receptor II. |
| Sandwich ELISA | sELISA: Use a concentration of 0.5 - 2 µg/ml. Can be paired for Sandwich ELISA with Rabbit polyclonal to Soluble TNF Receptor II (Biotin) (ab83158). (using 100 µl/well antibody solution). This antigen affinity purified antibody, in conjunction with ab83158 as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human soluble TNF Receptor II. |
| Neutralising | Neut: Use a concentration of 15 - 20 µg/ml. to yield one half maximal inhibition [ND50] of the biological activity of Human soluble TNF Receptor II (0.5 µg/ml) |
Target
- FunctionReceptor with high affinity for TNFSF2/TNF-alpha and approximately 5-fold lower affinity for homotrimeric TNFSF1/lymphotoxin-alpha. The TRAF1/TRAF2 complex recruits the apoptotic suppressors BIRC2 and BIRC3 to TNFRSF1B/TNFR2. This receptor mediates most of the metabolic effects of TNF-alpha. Isoform 2 blocks TNF-alpha-induced apoptosis, which suggests that it regulates TNF-alpha function by antagonizing its biological activity.
- Sequence similaritiesContains 4 TNFR-Cys repeats.
- Post-translational
modificationsPhosphorylated; mainly on serine residues and with a very low level on threonine residues.
A soluble form (tumor necrosis factor binding protein 2) is produced from the membrane form by proteolytic processing. - Cellular localizationSecreted and Cell membrane.
-
Database links
- Entrez Gene: 7133 Human
- Omim: 191191 Human
- SwissProt: P20333 Human
- Unigene: 256278 Human
Target information above from: UniProt accession
P20333
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
-
Alternative names
- CD120b antibodyp75 antibodyp75 TNF receptor antibody
- p75TNFR antibodyp80 TNF alpha receptor antibodyp80 TNF-alpha receptor antibodySoluble TNFR1B variant 1 antibodyTBP-2 antibodyTBPII antibodyTNF R II antibodyTNF R2 antibodyTNF R75 antibodyTNF-R2 antibodyTNF-RII antibodyTNFBR antibodyTNFR-II antibodyTNFR1B antibodyTNFR2 antibodyTNFR80 antibodyTnfrsf1b antibodyTNR1B_HUMAN antibodyTumor necrosis factor beta receptor antibodyTumor necrosis factor binding protein 2 antibodyTumor necrosis factor receptor 2 antibodyTumor necrosis factor receptor superfamily, member 1B antibodyTumor necrosis factor receptor type II antibodyTumor necrosis factor-binding protein 2 antibody
see all
References for Anti-Soluble TNF Receptor II antibody (ab109853)
ab109853 has not yet been referenced specifically in any publications.
